{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:01Z","timestamp":1792790521292,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24CDA1269588"],"award-info":[{"award-number":["24CDA1269588"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03924-x","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:26:34Z","timestamp":1782962794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microglial checkpoint collapse in Alzheimer\u2019s disease: a tri-axial framework for biomarker-informed neuroimmune therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiahao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peibin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"4","key":"3924_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"3924_CR2","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3924_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"3924_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"11","key":"3924_CR5","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023;146(11):4414\u201324.","journal-title":"Brain"},{"issue":"1","key":"3924_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamaneurol.2024.3937","volume":"82","author":"S Salloway","year":"2025","unstructured":"Salloway S, Wojtowicz J, Voyle N, Lane CA, Klein G, Lyons M, Rossomanno S, Mazzo F, Bullain S, Barkhof F, et al. Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease. JAMA Neurol. 2025;82(1):19\u201329.","journal-title":"JAMA Neurol"},{"issue":"1","key":"3924_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41593-025-02125-8","volume":"29","author":"G Albertini","year":"2026","unstructured":"Albertini G, Zielonka M, Cuypers ML, Snellinx A, Xu C, Poovathingal S, Wojno M, Davie K, van Lieshout V, Craessaerts K, et al. The Alzheimer\u2019s therapeutic Lecanemab attenuates A\u03b2 pathology by inducing an amyloid-clearing program in microglia. Nat Neurosci. 2026;29(1):100\u201310.","journal-title":"Nat Neurosci"},{"key":"3924_CR8","doi-asserted-by":"publisher","first-page":"1412006","DOI":"10.3389\/fnagi.2024.1412006","volume":"16","author":"KE Foley","year":"2024","unstructured":"Foley KE, Wilcock DM. Three major effects of APOE(\u03b54) on A\u03b2 immunotherapy induced ARIA. Front Aging Neurosci. 2024;16:1412006.","journal-title":"Front Aging Neurosci"},{"key":"3924_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3924_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17(1):131\u201343.","journal-title":"Nat Neurosci"},{"issue":"10","key":"3924_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19(10):622\u201335.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"3924_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"8","key":"3924_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987\u201391.","journal-title":"Nat Neurosci"},{"issue":"21","key":"3924_CR14","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, Amit I, Audinat E, Bechmann I, Bennett M, et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110(21):3458\u201383.","journal-title":"Neuron"},{"issue":"7","key":"3924_CR15","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169(7):1276\u2013e12901217.","journal-title":"Cell"},{"issue":"5","key":"3924_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell. 2018;173(5):1073\u201381.","journal-title":"Cell"},{"issue":"2","key":"3924_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V, Hahn O, Morgens DW, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"5","key":"3924_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","volume":"141","author":"E Gerrits","year":"2021","unstructured":"Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, Mulder J, Kummer M, M\u00f6ller T, Biber K, et al. Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease. Acta Neuropathol. 2021;141(5):681\u201396.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"3924_CR19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan S, Besson-Girard S, Kaya T, Cantuti-Castelvetri L, Liu L, Ji H, Schifferer M, Gouna G, Usifo F, Kannaiyan N, et al. White matter aging drives microglial diversity. Neuron. 2021;109(7):1100\u2013e11171110.","journal-title":"Neuron"},{"issue":"8026","key":"3924_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","volume":"632","author":"H Mathys","year":"2024","unstructured":"Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP, Jiang X, Abdelhady G, Galani K, Mantero J, et al. Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature. 2024;632(8026):858\u201368.","journal-title":"Nature"},{"issue":"1","key":"3924_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41467-025-56124-1","volume":"16","author":"R Martins-Ferreira","year":"2025","unstructured":"Martins-Ferreira R, Calafell-Segura J, Leal B, Rodr\u00edguez-Ubreva J, Mart\u00ednez-Saez E, Mereu E, Pinho ECP, Laguna A, Ballestar E. The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nat Commun. 2025;16(1):739.","journal-title":"Nat Commun"},{"issue":"7","key":"3924_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41593-025-01931-4","volume":"28","author":"L Fumagalli","year":"2025","unstructured":"Fumagalli L, Nazlie Mohebiany A, Premereur J, Polanco Miquel P, Bijnens B, Van de Walle P, Fattorelli N, Mancuso R. Microglia heterogeneity, modeling and cell-state annotation in development and neurodegeneration. Nat Neurosci. 2025;28(7):1381\u201392.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3924_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):66.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"3924_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M. TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018;14(11):667\u201375.","journal-title":"Nat Rev Neurol"},{"key":"3924_CR25","doi-asserted-by":"crossref","unstructured":"Mendsaikhan A, Tooyama I, Walker DG. Microglial Progranulin: Involvement in Alzheimer\u2019s Disease and Neurodegenerative Diseases. Cells. 2019;8(3):230.","DOI":"10.3390\/cells8030230"},{"issue":"18","key":"3924_CR26","doi-asserted-by":"publisher","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","volume":"95","author":"JK Harrison","year":"1998","unstructured":"Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A. 1998;95(18):10896\u2013901.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3924_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A, et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16(7):848\u201350.","journal-title":"Nat Neurosci"},{"issue":"4","key":"3924_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631\u201343.","journal-title":"Neuron"},{"issue":"11","key":"3924_CR29","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, Zhang X, Brand\u00e3o W, Margeta MA, Schroeder C, Sivanathan KN, Silveira S, Gauthier C, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat Immunol. 2023;24(11):1839\u201353.","journal-title":"Nat Immunol"},{"issue":"8006","key":"3924_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, Dong W, Rawat E, West E, Schlachetzki JCM, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. 2024;628(8006):154\u201361.","journal-title":"Nature"},{"issue":"8","key":"3924_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","volume":"29","author":"MB Victor","year":"2022","unstructured":"Victor MB, Leary N, Luna X, Meharena HS, Scannail AN, Bozzelli PL, Samaan G, Murdock MH, von Maydell D, Effenberger AH, et al. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell. 2022;29(8):1197\u2013e12121198.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3924_CR32","doi-asserted-by":"publisher","first-page":"e14541","DOI":"10.1002\/alz.14541","volume":"21","author":"MA Thorwald","year":"2025","unstructured":"Thorwald MA, Godoy-Lugo JA, Garcia G, Silva J, Kim M, Christensen A, Mack WJ, Head E, O\u2019Day PA, Benayoun BA, et al. Iron-associated lipid peroxidation in Alzheimer\u2019s disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice. Alzheimers Dement. 2025;21(1):e14541.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3924_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","volume":"26","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M, Shankara S, Guo L, Li C, Pontarelli F, et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat Neurosci. 2023;26(1):12\u201326.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3924_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","volume":"19","author":"JR Liddell","year":"2024","unstructured":"Liddell JR, Hilton JBW, Kysenius K, Billings JL, Nikseresht S, McInnes LE, Hare DJ, Paul B, Mercer SW, Belaidi AA, et al. Microglial ferroptotic stress causes non-cell autonomous neuronal death. Mol Neurodegener. 2024;19(1):14.","journal-title":"Mol Neurodegener"},{"issue":"7784","key":"3924_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"issue":"7685","key":"3924_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature. 2017;552(7685):355\u201361.","journal-title":"Nature"},{"issue":"6286","key":"3924_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"issue":"8","key":"3924_CR38","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","volume":"28","author":"T Wu","year":"2019","unstructured":"Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S, Srinivasan K, Huntley MA, Wang Y, Wang TM, et al. Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. Cell Rep. 2019;28(8):2111\u2013e21232116.","journal-title":"Cell Rep"},{"issue":"23","key":"3924_CR39","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1016\/j.neuron.2024.09.006","volume":"112","author":"GK Carling","year":"2024","unstructured":"Carling GK, Fan L, Foxe NR, Norman K, Wong MY, Zhu D, Corona C, Razzoli A, Yu F, Yarahmady A, et al. Alzheimer\u2019s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. Neuron. 2024;112(23):3877\u2013e38963878.","journal-title":"Neuron"},{"issue":"3","key":"3924_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019Loughlin E, Xu Y, Fanek Z, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566\u2013e5819.","journal-title":"Immunity"},{"issue":"4","key":"3924_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","volume":"140","author":"AT Nguyen","year":"2020","unstructured":"Nguyen AT, Wang K, Hu G, Wang X, Miao Z, Azevedo JA, Suh E, Van Deerlin VM, Choi D, Roeder K, et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140(4):477\u201393.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3924_CR42","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, Cimpean M, Khairallah A, Coronas-Samano G, Sankowski R, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun. 2020;11(1):6129.","journal-title":"Nat Commun"},{"issue":"1","key":"3924_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26(1):131\u201342.","journal-title":"Nat Med"},{"issue":"4","key":"3924_CR44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, Mancuso R, Chen WT, Woodbury ME, Srivastava G, et al. The Major Risk Factors for Alzheimer\u2019s Disease: Age, Sex, and Genes Modulate the Microglia Response to A\u03b2 Plaques. Cell Rep. 2019;27(4):1293\u2013e13061296.","journal-title":"Cell Rep"},{"issue":"4","key":"3924_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"6","key":"3924_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160(6):1061\u201371.","journal-title":"Cell"},{"key":"3924_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2017.00204","volume":"9","author":"L Zhong","year":"2017","unstructured":"Zhong L, Zhang ZL, Li X, Liao C, Mou P, Wang T, Wang Z, Wang Z, Wei M, Xu H, et al. TREM2\/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway. Front Aging Neurosci. 2017;9:204.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3924_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, et al. Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimers Dement. 2011;7(4):402\u201311.","journal-title":"Alzheimers Dement"},{"issue":"18","key":"3924_CR49","doi-asserted-by":"publisher","first-page":"e2070","DOI":"10.1212\/WNL.0000000000007232","volume":"92","author":"PF Meyer","year":"2019","unstructured":"Meyer PF, Tremblay-Mercier J, Leoutsakos J, Madjar C, Lafaille-Magnan ME, Savard M, Rosa-Neto P, Poirier J, Etienne P, Breitner J. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology. 2019;92(18):e2070\u201380.","journal-title":"Neurology"},{"issue":"18","key":"3924_CR50","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","volume":"88","author":"NR Relkin","year":"2017","unstructured":"Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, et al. A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology. 2017;88(18):1768\u201375.","journal-title":"Neurology"},{"issue":"1","key":"3924_CR51","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s42003-024-07057-w","volume":"7","author":"S Yasa","year":"2024","unstructured":"Yasa S, Butz ES, Colombo A, Chandrachud U, Montore L, Tschirner S, Prestel M, Sheridan SD, M\u00fcller SA, Groh J, et al. Loss of CLN3 in microglia leads to impaired lipid metabolism and myelin turnover. Commun Biol. 2024;7(1):1373.","journal-title":"Commun Biol"},{"issue":"7498","key":"3924_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014;509(7498):105\u20139.","journal-title":"Nature"},{"key":"3924_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","volume":"14","author":"S Masaldan","year":"2018","unstructured":"Masaldan S, Clatworthy SAS, Gamell C, Meggyesy PM, Rigopoulos AT, Haupt S, Haupt Y, Denoyer D, Adlard PA, Bush AI, et al. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol. 2018;14:100\u201315.","journal-title":"Redox Biol"},{"key":"3924_CR54","doi-asserted-by":"publisher","first-page":"103473","DOI":"10.1016\/j.redox.2024.103473","volume":"79","author":"H Zhang","year":"2025","unstructured":"Zhang H, Yang S, Lu YL, Zhou LQ, Dong MH, Chu YH, Pang XW, Chen L, Xu LL, Zhang LY, et al. Microglial Nrf2-mediated lipid and iron metabolism reprogramming promotes remyelination during white matter ischemia. Redox Biol. 2025;79:103473.","journal-title":"Redox Biol"},{"issue":"5","key":"3924_CR55","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","volume":"187","author":"B Qiu","year":"2024","unstructured":"Qiu B, Zandkarimi F, Bezjian CT, Reznik E, Soni RK, Gu W, Jiang X, Stockwell BR. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell. 2024;187(5):1177\u2013e11901118.","journal-title":"Cell"},{"issue":"9","key":"3924_CR56","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic B, Wu T, Tsai MC, Graykowski D, Gandham VD, Rose CM, Bakalarski CE, Ngu H, Wang Y, Pandey S, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nat Aging. 2022;2(9):837\u201350.","journal-title":"Nat Aging"},{"issue":"1","key":"3924_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1189\/jlb.3VMA1215-579RR","volume":"101","author":"SH Yeon","year":"2017","unstructured":"Yeon SH, Yang G, Lee HE, Lee JY. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages. J Leukoc Biol. 2017;101(1):205\u201315.","journal-title":"J Leukoc Biol"},{"issue":"7638","key":"3924_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"7883","key":"3924_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","volume":"599","author":"KA Guttenplan","year":"2021","unstructured":"Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, M\u00fcnch AE, Blum JA, Fine J, Neal MC, et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599(7883):102\u20137.","journal-title":"Nature"},{"issue":"3","key":"3924_CR60","doi-asserted-by":"publisher","first-page":"e00519","DOI":"10.1016\/j.neurot.2024.e00519","volume":"22","author":"HR Hudson","year":"2025","unstructured":"Hudson HR, Sun X, Orr ME. Senescent brain cell types in Alzheimer\u2019s disease: Pathological mechanisms and therapeutic opportunities. Neurotherapeutics. 2025;22(3):e00519.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"3924_CR61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jnc.14860","volume":"151","author":"DM Angelova","year":"2019","unstructured":"Angelova DM, Brown DR. Microglia and the aging brain: are senescent microglia the key to neurodegeneration? J Neurochem. 2019;151(6):676\u201388.","journal-title":"J Neurochem"},{"issue":"5","key":"3924_CR62","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, Bu G. ApoE4 Accelerates Early Seeding of Amyloid Pathology. Neuron. 2017;96(5):1024\u2013e10321023.","journal-title":"Neuron"},{"issue":"9","key":"3924_CR63","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"3924_CR64","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109(10):1657\u2013e16741657.","journal-title":"Neuron"},{"issue":"10","key":"3924_CR65","doi-asserted-by":"publisher","first-page":"113183","DOI":"10.1016\/j.celrep.2023.113183","volume":"42","author":"H Lee","year":"2023","unstructured":"Lee H, Cho S, Kim MJ, Park YJ, Cho E, Jo YS, Kim YS, Lee JY, Thoudam T, Woo SH, et al. ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes. Cell Rep. 2023;42(10):113183.","journal-title":"Cell Rep"},{"issue":"2","key":"3924_CR66","doi-asserted-by":"publisher","first-page":"e17175","DOI":"10.15252\/emmm.202217175","volume":"15","author":"M Arbaizar-Rovirosa","year":"2023","unstructured":"Arbaizar-Rovirosa M, Pedragosa J, Lozano JJ, Casal C, Pol A, Gallizioli M, Planas AM. Aged lipid-laden microglia display impaired responses to stroke. EMBO Mol Med. 2023;15(2):e17175.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3924_CR67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41514-025-00295-0","volume":"12","author":"S Sung","year":"2025","unstructured":"Sung S, Kim HJ, Cha SJ, Nahm M, Kim SH, Kwon MS. Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases. NPJ Aging. 2025;12(1):2.","journal-title":"NPJ Aging"},{"issue":"6","key":"3924_CR68","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.immuni.2025.04.029","volume":"58","author":"P Prakash","year":"2025","unstructured":"Prakash P, Manchanda P, Paouri E, Bisht K, Sharma K, Rajpoot J, Wendt V, Hossain A, Wijewardhane PR, Randolph CE, et al. Amyloid-\u03b2 induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer\u2019s disease. Immunity. 2025;58(6):1536\u2013e15521538.","journal-title":"Immunity"},{"issue":"3","key":"3924_CR69","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","volume":"112","author":"A Litvinchuk","year":"2024","unstructured":"Litvinchuk A, Suh JH, Guo JL, Lin K, Davis SS, Bien-Ly N, Tycksen E, Tabor GT, Remolina Serrano J, Manis M, et al. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron. 2024;112(3):384\u2013e403388.","journal-title":"Neuron"},{"issue":"11","key":"3924_CR70","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1073\/pnas.112059299","volume":"99","author":"SB Joseph","year":"2002","unstructured":"Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A. 2002;99(11):7604\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6036","key":"3924_CR71","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429\u201333.","journal-title":"Science"},{"issue":"5","key":"3924_CR72","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J, Kim DJ, Xia D, et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron. 2020;105(5):837\u2013e854839.","journal-title":"Neuron"},{"issue":"1","key":"3924_CR73","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s42003-022-04011-6","volume":"5","author":"P Baloni","year":"2022","unstructured":"Baloni P, Arnold M, Buitrago L, Nho K, Moreno H, Huynh K, Brauner B, Louie G, Kueider-Paisley A, Suhre K, et al. Multi-Omic analyses characterize the ceramide\/sphingomyelin pathway as a therapeutic target in Alzheimer\u2019s disease. Commun Biol. 2022;5(1):1074.","journal-title":"Commun Biol"},{"issue":"1","key":"3924_CR74","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11357-023-00989-x","volume":"46","author":"F Dakterzada","year":"2024","unstructured":"Dakterzada F, Jov\u00e9 M, Huerto R, Carnes A, Sol J, Pamplona R, Pi\u00f1ol-Ripoll G. Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer\u2019s disease. Geroscience. 2024;46(1):683\u201396.","journal-title":"Geroscience"},{"issue":"1","key":"3924_CR75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12974-025-03470-y","volume":"22","author":"M Hell\u00e9n","year":"2025","unstructured":"Hell\u00e9n M, Weert I, M\u00fcller SA, R\u00e4s\u00e4nen N, Kettunen P, Lehtonen \u0160, Peitz M, Flie\u00dfbach K, Takalo M, Koskuvi M, et al. Inflammation-induced lysosomal dysfunction in human iPSC-derived microglia is exacerbated by APOE 4\/4 genotype. J Neuroinflammation. 2025;22(1):147.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3924_CR76","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2020;324(8):772\u201381.","journal-title":"JAMA"},{"issue":"20","key":"3924_CR77","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1074\/jbc.RA118.001949","volume":"293","author":"RC McCarthy","year":"2018","unstructured":"McCarthy RC, Sosa JC, Gardeck AM, Baez AS, Lee CH, Wessling-Resnick M. Inflammation-induced iron transport and metabolism by brain microglia. J Biol Chem. 2018;293(20):7853\u201363.","journal-title":"J Biol Chem"},{"issue":"1","key":"3924_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40478-021-01126-5","volume":"9","author":"B Kenkhuis","year":"2021","unstructured":"Kenkhuis B, Somarakis A, de Haan L, Dzyubachyk O, ME IJ, de Miranda N, Lelieveldt BPF, Dijkstra J, van Roon-Mom WMC, H\u00f6llt T, et al. Iron loading is a prominent feature of activated microglia in Alzheimer\u2019s disease patients. Acta Neuropathol Commun. 2021;9(1):27.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"3924_CR79","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/brain\/awaa089","volume":"143","author":"N Spotorno","year":"2020","unstructured":"Spotorno N, Acosta-Cabronero J, Stomrud E, Lampinen B, Strandberg OT, van Westen D, Hansson O. Relationship between cortical iron and tau aggregation in Alzheimer\u2019s disease. Brain. 2020;143(5):1341\u20139.","journal-title":"Brain"},{"key":"3924_CR80","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1038\/ncomms7760","volume":"6","author":"S Ayton","year":"2015","unstructured":"Ayton S, Faux NG, Bush AI. Ferritin levels in the cerebrospinal fluid predict Alzheimer\u2019s disease outcomes and are regulated by APOE. Nat Commun. 2015;6:6760.","journal-title":"Nat Commun"},{"issue":"11","key":"3924_CR81","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","volume":"25","author":"S Ayton","year":"2020","unstructured":"Ayton S, Wang Y, Diouf I, Schneider JA, Brockman J, Morris MC, Bush AI. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry. 2020;25(11):2932\u201341.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"3924_CR82","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1093\/brain\/awx137","volume":"140","author":"S Ayton","year":"2017","unstructured":"Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, et al. Cerebral quantitative susceptibility mapping predicts amyloid-\u03b2-related cognitive decline. Brain. 2017;140(8):2112\u20139.","journal-title":"Brain"},{"issue":"3","key":"3924_CR83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/jnnp-2022-330052","volume":"94","author":"S Ayton","year":"2023","unstructured":"Ayton S, Janelidze S, Kalinowski P, Palmqvist S, Belaidi AA, Stomrud E, Roberts A, Roberts B, Hansson O, Bush AI. CSF ferritin in the clinicopathological progression of Alzheimer\u2019s disease and associations with APOE and inflammation biomarkers. J Neurol Neurosurg Psychiatry. 2023;94(3):211\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"3924_CR84","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"12","key":"3924_CR85","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391.","journal-title":"Nat Cell Biol"},{"issue":"7784","key":"3924_CR86","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"key":"3924_CR87","doi-asserted-by":"crossref","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier, da Silva TN, Panzilius E, Scheel CH et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u2013698.","DOI":"10.1038\/s41586-019-1707-0"},{"key":"3924_CR88","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2022.12.086","volume":"195","author":"H Bouchaoui","year":"2023","unstructured":"Bouchaoui H, Mahoney-Sanchez L, Gar\u00e7on G, Berdeaux O, Alleman LY, Devos D, Duce JA, Devedjian JC. ACSL4 and the lipoxygenases 15\/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons. Free Radic Biol Med. 2023;195:145\u201357.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3924_CR89","doi-asserted-by":"publisher","first-page":"25845","DOI":"10.31083\/JIN25845","volume":"24","author":"J Xu","year":"2025","unstructured":"Xu J, Shen R, Qian M, Zhou Z, Xie B, Jiang Y, Yu Y, Dong W. Ferroptosis in Alzheimer\u2019s Disease: The Regulatory Role of Glial Cells. J Integr Neurosci. 2025;24(4):25845.","journal-title":"J Integr Neurosci"},{"issue":"6","key":"3924_CR90","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/ana.26770","volume":"94","author":"PA Adeniyi","year":"2023","unstructured":"Adeniyi PA, Gong X, MacGregor E, Degener-O\u2019Brien K, McClendon E, Garcia M, Romero O, Russell J, Srivastava T, Miller J, et al. Ferroptosis of Microglia in Aging Human White Matter Injury. Ann Neurol. 2023;94(6):1048\u201366.","journal-title":"Ann Neurol"},{"issue":"1","key":"3924_CR91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaneurol.2024.3733","volume":"82","author":"S Ayton","year":"2025","unstructured":"Ayton S, Barton D, Brew B, Brodtmann A, Clarnette R, Desmond P, Devos D, Ellis KA, Fazlollahi A, Fradette C, et al. Deferiprone in Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurol. 2025;82(1):11\u20138.","journal-title":"JAMA Neurol"},{"issue":"5","key":"3924_CR92","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","volume":"28","author":"WD Bao","year":"2021","unstructured":"Bao WD, Pang P, Zhou XT, Hu F, Xiong W, Chen K, Wang J, Wang F, Xie D, Hu YZ, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease. Cell Death Differ. 2021;28(5):1548\u201362.","journal-title":"Cell Death Differ"},{"key":"3924_CR93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","volume":"12","author":"WS Hambright","year":"2017","unstructured":"Hambright WS, Fonseca RS, Chen L, Na R, Ran Q. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol. 2017;12:8\u201317.","journal-title":"Redox Biol"},{"issue":"2","key":"3924_CR94","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11(2):155\u201361.","journal-title":"Nat Immunol"},{"issue":"8","key":"3924_CR95","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013;14(8):812\u201320.","journal-title":"Nat Immunol"},{"issue":"22","key":"3924_CR96","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, Lei T, Hou J, Cai Z, Cella M, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185(22):4153\u2013e41694119.","journal-title":"Cell"},{"issue":"4","key":"3924_CR97","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, Werner G, Pettkus N, Brunner B, et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12(4):e11227.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3924_CR98","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/s41467-021-22301-1","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding X, Wang J, Huang M, Chen Z, Liu J, Zhang Q, Zhang C, Xiang Y, Zen K, Li L. Loss of microglial SIRP\u03b1 promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun. 2021;12(1):2030.","journal-title":"Nat Commun"},{"issue":"1","key":"3924_CR99","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuron.2018.09.017","volume":"100","author":"EK Lehrman","year":"2018","unstructured":"Lehrman EK, Wilton DK, Litvina EY, Welsh CA, Chang ST, Frouin A, Walker AJ, Heller MD, Umemori H, Chen C, et al. CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development. Neuron. 2018;100(1):120\u2013e134126.","journal-title":"Neuron"},{"issue":"7","key":"3924_CR100","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3924_CR101","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Br\u00f4ne B, Huaux F, Octave JN, et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol. 2019;137(4):599\u2013617.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3924_CR102","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, Tousseyn T, De Strooper B, Thal DR. Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2023;145(2):175\u201395.","journal-title":"Acta Neuropathol"},{"key":"3924_CR103","doi-asserted-by":"publisher","first-page":"1583886","DOI":"10.3389\/fimmu.2025.1583886","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Gong C. NLRP3 inflammasome in Alzheimer\u2019s disease: molecular mechanisms and emerging therapies. Front Immunol. 2025;16:1583886.","journal-title":"Front Immunol"},{"issue":"2","key":"3924_CR104","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2025.01.007","volume":"58","author":"RM McManus","year":"2025","unstructured":"McManus RM, Komes MP, Griep A, Santarelli F, Schwartz S, Ram\u00f3n Perea J, Schlachetzki JCM, Bouvier DS, Khalil MA, Lauterbach MA, et al. NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer\u2019s disease progression. Immunity. 2025;58(2):326\u2013e343311.","journal-title":"Immunity"},{"key":"3924_CR105","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun. 2017;61:306\u201316.","journal-title":"Brain Behav Immun"},{"issue":"50","key":"3924_CR106","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A, Dinarello CA, Korte M. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2020;117(50):32145\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"3924_CR107","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","volume":"66","author":"D Harrison","year":"2023","unstructured":"Harrison D, Billinton A, Bock MG, Doedens JR, Gabel CA, Holloway MK, Porter RA, Reader V, Scanlon J, Schooley K, et al. Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders. J Med Chem. 2023;66(21):14897\u2013911.","journal-title":"J Med Chem"},{"issue":"1","key":"3924_CR108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44400-025-00011-5","volume":"1","author":"A Auger","year":"2025","unstructured":"Auger A, Faidi R, Rickman AD, Martinez CP, Fajfer A, Carling J, Hilyard A, Ali M, Ono R, Cleveland C, et al. Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration. NPJ Dement. 2025;1(1):3.","journal-title":"NPJ Dement"},{"issue":"4","key":"3924_CR109","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74(4):691\u2013705.","journal-title":"Neuron"},{"issue":"10","key":"3924_CR110","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","volume":"26","author":"SH Krance","year":"2021","unstructured":"Krance SH, Wu CY, Zou Y, Mao H, Toufighi S, He X, Pakosh M, Swardfager W. The complement cascade in Alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2021;26(10):5532\u201341.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"3924_CR111","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Mazi\u00e8re A, Meilandt WJ, Wu T, Srinivasan K, Jiang Z, Gandham V, Friedman BA, Ngu H, et al. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. Neuron. 2018;100(6):1322\u2013e13361327.","journal-title":"Neuron"},{"issue":"6","key":"3924_CR112","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1091581817740873","volume":"36","author":"JA Lansita","year":"2017","unstructured":"Lansita JA, Mease KM, Qiu H, Yednock T, Sankaranarayanan S, Kramer S. Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases. Int J Toxicol. 2017;36(6):449\u201362.","journal-title":"Int J Toxicol"},{"issue":"8","key":"3924_CR113","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.tips.2022.01.004","volume":"43","author":"C Lamers","year":"2022","unstructured":"Lamers C, Mastellos DC, Ricklin D, Lambris JD. Compstatins: the dawn of clinical C3-targeted complement inhibition. Trends Pharmacol Sci. 2022;43(8):629\u201340.","journal-title":"Trends Pharmacol Sci"},{"issue":"37","key":"3924_CR114","doi-asserted-by":"publisher","first-page":"32713","DOI":"10.1074\/jbc.M111.254268","volume":"286","author":"SH Cho","year":"2011","unstructured":"Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem. 2011;286(37):32713\u201322.","journal-title":"J Biol Chem"},{"issue":"5","key":"3924_CR115","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","volume":"26","author":"JC Udeochu","year":"2023","unstructured":"Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, Liu B, McGurran H, Coronas-Samano G, Kauwe G, et al. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023;26(5):737\u201350.","journal-title":"Nat Neurosci"},{"issue":"3","key":"3924_CR116","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","volume":"129","author":"C Cantoni","year":"2015","unstructured":"Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, Yuede CM, Galimberti D, Olivecrona G, Klein RS, et al. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol. 2015;129(3):429\u201347.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3924_CR117","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron A, Larochelle A, Laflamme N, Pr\u00e9fontaine P, Plante MM, S\u00e1nchez MG, Yong VW, Stys PK, Tremblay M, Rivest S. Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med. 2015;212(4):481\u201395.","journal-title":"J Exp Med"},{"issue":"6","key":"3924_CR118","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1212\/NXI.0000000000000402","volume":"4","author":"LM Healy","year":"2017","unstructured":"Healy LM, Jang JH, Won SY, Lin YH, Touil H, Aljarallah S, Bar-Or A, Antel JP. MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS. Neurol Neuroimmunol Neuroinflamm. 2017;4(6):e402.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"3924_CR119","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE. The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol. 2019;15(8):447\u201358.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"3924_CR120","doi-asserted-by":"publisher","first-page":"108835","DOI":"10.1016\/j.celrep.2021.108835","volume":"34","author":"K Shen","year":"2021","unstructured":"Shen K, Reichelt M, Kyauk RV, Ngu H, Shen YA, Foreman O, Modrusan Z, Friedman BA, Sheng M, Yuen TJ. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination. Cell Rep. 2021;34(10):108835.","journal-title":"Cell Rep"},{"issue":"5","key":"3924_CR121","doi-asserted-by":"publisher","first-page":"106588","DOI":"10.1016\/j.isci.2023.106588","volume":"26","author":"C Qin","year":"2023","unstructured":"Qin C, Yang S, Chen M, Dong MH, Zhou LQ, Chu YH, Shen ZX, Bosco DB, Wu LJ, Tian DS, et al. Modulation of microglial metabolism facilitates regeneration in demyelination. iScience. 2023;26(5):106588.","journal-title":"iScience"},{"issue":"7937","key":"3924_CR122","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, Effenberger A, Chen CY, Maner-Smith K, Hajjar I, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611(7937):769\u201379.","journal-title":"Nature"},{"issue":"5","key":"3924_CR123","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1002\/alz.13776","volume":"20","author":"T Qiu","year":"2024","unstructured":"Qiu T, Liu ZQ, Rheault F, Legarreta JH, Valcourt Caron A, St-Onge F, Strikwerda-Brown C, Metz A, Dadar M, Soucy JP, et al. Structural white matter properties and cognitive resilience to tau pathology. Alzheimers Dement. 2024;20(5):3364\u201377.","journal-title":"Alzheimers Dement"},{"key":"3924_CR124","doi-asserted-by":"publisher","first-page":"1412735","DOI":"10.3389\/fnagi.2024.1412735","volume":"16","author":"TR Li","year":"2024","unstructured":"Li TR, Li BL, Xu XR, Zhong J, Wang TS, Liu FQ. Association of white matter hyperintensities with cognitive decline and neurodegeneration. Front Aging Neurosci. 2024;16:1412735.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"3924_CR125","doi-asserted-by":"publisher","first-page":"e14594","DOI":"10.1002\/alz.14594","volume":"21","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhou X, Xiao Z, Zhao Q, Ding D, Zhang J. White matter injury, plasma Alzheimer\u2019s disease, and neurodegenerative biomarkers on cognitive decline in community-dwelling older adults: A 10-year longitudinal study. Alzheimers Dement. 2025;21(2):e14594.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3924_CR126","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/13872877251360239","volume":"107","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Bao J, Wang T, Shang L, Chu S, Jin W, Wang W, Jiang Y, Li B, Huang Y, et al. Global and regional white matter hyperintensities in Alzheimer\u2019s disease: Exploring etiologies and cognitive correlates. J Alzheimers Dis. 2025;107(1):246\u201356.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3924_CR127","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","volume":"321","author":"JD Williamson","year":"2019","unstructured":"Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553\u201361.","journal-title":"JAMA"},{"issue":"6","key":"3924_CR128","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jama.2019.10551","volume":"322","author":"IM Nasrallah","year":"2019","unstructured":"Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA. 2019;322(6):524\u201334.","journal-title":"JAMA"},{"issue":"3","key":"3924_CR129","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, Steinh\u00e4user C, Volterra A, Carmignoto G, Agarwal A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312\u201325.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3924_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun. 2023;11(1):42.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3924_CR131","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1038\/s41467-020-17514-9","volume":"11","author":"KA Guttenplan","year":"2020","unstructured":"Guttenplan KA, Weigel MK, Adler DI, Couthouis J, Liddelow SA, Gitler AD, Barres BA. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun. 2020;11(1):3753.","journal-title":"Nat Commun"},{"issue":"7869","key":"3924_CR132","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","volume":"595","author":"CS McAlpine","year":"2021","unstructured":"McAlpine CS, Park J, Griciuc A, Kim E, Choi SH, Iwamoto Y, Kiss MG, Christie KA, Vinegoni C, Poller WC, et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease. Nature. 2021;595(7869):701\u20136.","journal-title":"Nature"},{"issue":"9","key":"3924_CR133","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41582-021-00546-0","volume":"17","author":"H Wood","year":"2021","unstructured":"Wood H. Astrocytic IL-3 could help microglia protect against Alzheimer disease. Nat Rev Neurol. 2021;17(9):525.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"3924_CR134","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, Zetterberg H, Stomrud E, Ashton NJ, Blennow K, et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain. 2021;144(11):3505\u201316.","journal-title":"Brain"},{"issue":"7","key":"3924_CR135","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, Benedet AL, Ashton NJ, Triana-Baltzer G, Kolb HC, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29(7):1775\u201381.","journal-title":"Nat Med"},{"issue":"1","key":"3924_CR136","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2024","unstructured":"Pelkmans W, Shekari M, Brugulat-Serrat A, S\u00e1nchez-Benavides G, Minguill\u00f3n C, Fauria K, Molinuevo JL, Grau-Rivera O, Gonz\u00e1lez Escalante A, Kollmorgen G, et al. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression. Alzheimers Dement. 2024;20(1):483\u201393.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"3924_CR137","doi-asserted-by":"publisher","first-page":"e209537","DOI":"10.1212\/WNL.0000000000209537","volume":"103","author":"S Holper","year":"2024","unstructured":"Holper S, Loveland P, Churilov L, Italiano D, Watson R, Yassi N. Blood Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-Analysis. Neurology. 2024;103(3):e209537.","journal-title":"Neurology"},{"issue":"6","key":"3924_CR138","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H. Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry. 2025;30(6):2783\u201398.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"3924_CR139","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s43587-021-00142-3","volume":"1","author":"SK Dehkordi","year":"2021","unstructured":"Dehkordi SK, Walker J, Sah E, Bennett E, Atrian F, Frost B, Woost B, Bennett RE, Orr TC, Zhou Y, et al. Profiling senescent cells in human brains reveals neurons with CDKN2D\/p19 and tau neuropathology. Nat Aging. 2021;1(12):1107\u201316.","journal-title":"Nat Aging"},{"issue":"12","key":"3924_CR140","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.stem.2022.11.010","volume":"29","author":"JR Herdy","year":"2022","unstructured":"Herdy JR, Traxler L, Agarwal RK, Karbacher L, Schlachetzki JCM, Boehnke L, Zangwill D, Galasko D, Glass CK, Mertens J, et al. Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer\u2019s disease. Cell Stem Cell. 2022;29(12):1637\u2013e16521636.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3924_CR141","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00401-024-02727-9","volume":"147","author":"NN Fancy","year":"2024","unstructured":"Fancy NN, Smith AM, Caramello A, Tsartsalis S, Davey K, Muirhead RCJ, McGarry A, Jenkyns MH, Schneegans E, Chau V, et al. Characterisation of premature cell senescence in Alzheimer\u2019s disease using single nuclear transcriptomics. Acta Neuropathol. 2024;147(1):78.","journal-title":"Acta Neuropathol"},{"issue":"7728","key":"3924_CR142","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018;562(7728):578\u201382.","journal-title":"Nature"},{"issue":"5","key":"3924_CR143","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S, Abdelmohsen K, Bohr VA, Misra Sen J, Gorospe M, et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat Neurosci. 2019;22(5):719\u201328.","journal-title":"Nat Neurosci"},{"issue":"4","key":"3924_CR144","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3233\/JAD-230465","volume":"97","author":"PY Ng","year":"2024","unstructured":"Ng PY, Zhang C, Li H, Baker DJ. Senescence Targeting Methods Impact Alzheimer\u2019s Disease Features in 3xTg Mice. J Alzheimers Dis. 2024;97(4):1751\u201363.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"3924_CR145","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","volume":"29","author":"MM Gonzales","year":"2023","unstructured":"Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez-Cruzan M, Dehkordi SK, Mathews JJ, Zare H, Xu P, Zhang B, et al. Senolytic therapy in mild Alzheimer\u2019s disease: a phase 1 feasibility trial. Nat Med. 2023;29(10):2481\u20138.","journal-title":"Nat Med"},{"issue":"4","key":"3924_CR146","doi-asserted-by":"publisher","first-page":"e00591","DOI":"10.1016\/j.neurot.2025.e00591","volume":"22","author":"VR Garbarino","year":"2025","unstructured":"Garbarino VR, Palavicini JP, Melendez J, Barthelemy NR, He Y, Kautz TF, Lopez-Cruzan M, Mathews JJ, Xu P, Zhang B, et al. Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer\u2019s disease. Neurotherapeutics. 2025;22(4):e00591.","journal-title":"Neurotherapeutics"},{"key":"3924_CR147","doi-asserted-by":"publisher","first-page":"105612","DOI":"10.1016\/j.ebiom.2025.105612","volume":"113","author":"CL Millar","year":"2025","unstructured":"Millar CL, Iloputaife I, Baldyga K, Norling AM, Boulougoura A, Vichos T, Tchkonia T, Deisinger A, Pirtskhalava T, Kirkland JL, et al. A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer\u2019s disease. EBioMedicine. 2025;113:105612.","journal-title":"EBioMedicine"},{"issue":"2","key":"3924_CR148","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41591-024-02802-4","volume":"30","author":"S Crespo-Garcia","year":"2024","unstructured":"Crespo-Garcia S, Fournier F, Diaz-Marin R, Klier S, Ragusa D, Masaki L, Cagnone G, Blot G, Hafiane I, Dejda A, et al. Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results. Nat Med. 2024;30(2):443\u201354.","journal-title":"Nat Med"},{"issue":"4","key":"3924_CR149","doi-asserted-by":"publisher","first-page":"633","DOI":"10.14283\/jpad.2023.104","volume":"10","author":"M Riessland","year":"2023","unstructured":"Riessland M, Orr ME. Translating the Biology of Aging into New Therapeutics for Alzheimer\u2019s Disease: Senolytics. J Prev Alzheimers Dis. 2023;10(4):633\u201346.","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"3924_CR150","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41591-024-02804-2","volume":"30","author":"T Murakami","year":"2024","unstructured":"Murakami T, Gardner TW. Rejuvenation of diabetic macular edema with senolytic therapy. Nat Med. 2024;30(2):346\u20137.","journal-title":"Nat Med"},{"key":"3924_CR151","doi-asserted-by":"crossref","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217(9):e20200785.","DOI":"10.1084\/jem.20200785"},{"issue":"3","key":"3924_CR152","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41593-022-01240-0","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, Tatarakis D, Calvert M, Hummel S, Lianoglou S, et al. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26(3):416\u201329.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3924_CR153","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","volume":"16","author":"H Long","year":"2024","unstructured":"Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, et al. Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16(1):235.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"3924_CR154","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41591-026-04273-1","volume":"32","author":"CJ Mummery","year":"2026","unstructured":"Mummery CJ, Mayorga AJ, Simmons A, Chow TW, Burgess B, Nguyen T, Gao J, Budda B, Park LQ, Gupta R, et al. The TREM2 agonistic antibody AL002 in early Alzheimer\u2019s disease: a phase 2 randomized trial. Nat Med. 2026;32(5):1708\u201316.","journal-title":"Nat Med"},{"key":"3924_CR155","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bbi.2024.03.017","volume":"118","author":"WM Zelek","year":"2024","unstructured":"Zelek WM, Bevan RJ, Morgan BP. Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia. Brain Behav Immun. 2024;118:355\u201363.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3924_CR156","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12967-023-04251-y","volume":"21","author":"M Kurnellas","year":"2023","unstructured":"Kurnellas M, Mitra A, Schwabe T, Paul R, Arrant AE, Roberson ED, Ward M, Yeh F, Long H, Rosenthal A. Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia. J Transl Med. 2023;21(1):387.","journal-title":"J Transl Med"},{"issue":"1","key":"3924_CR157","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","volume":"8","author":"JL Cummings","year":"2016","unstructured":"Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A, Pontecorvo M, Devous M, Tang A, Bena J. Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer\u2019s disease. Alzheimers Res Ther. 2016;8(1):4.","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"3924_CR158","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(21)00043-0","volume":"20","author":"DK Burns","year":"2021","unstructured":"Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O\u2019Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, et al. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer\u2019s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2021;20(7):537\u201347.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3924_CR159","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41433-024-03373-x","volume":"39","author":"JD Shirian","year":"2025","unstructured":"Shirian JD, Shukla P, Singh RP. Exploring new horizons in neovascular age-related macular degeneration: novel mechanisms of action and future therapeutic avenues. Eye (Lond). 2025;39(1):40\u20134.","journal-title":"Eye (Lond)"},{"issue":"1","key":"3924_CR160","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1111\/jns.70009","volume":"30","author":"QD Mohammad","year":"2025","unstructured":"Mohammad QD, Islam Z, Papri N, Hayat S, Jahan I, Azad KAK, Artis DR, Hoehn B, Humphriss E, Lin P, et al. Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain-Barr\u00e9 Syndrome. J Peripher Nerv Syst. 2025;30(1):e70009.","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"3924_CR161","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, Wykoff CC, Singerman LJ, Abraham P, Grassmann F, et al. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial. Ophthalmology. 2020;127(2):186\u201395.","journal-title":"Ophthalmology"},{"issue":"11","key":"3924_CR162","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa2029073","volume":"384","author":"P Hillmen","year":"2021","unstructured":"Hillmen P, Szer J, Weitz I, R\u00f6th A, H\u00f6chsmann B, Panse J, Usuki K, Griffin M, Kiladjian JJ, de Castro C, et al. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2021;384(11):1028\u201337.","journal-title":"N Engl J Med"},{"issue":"1","key":"3924_CR163","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1038\/s41467-022-33003-7","volume":"13","author":"C Lamers","year":"2022","unstructured":"Lamers C, Xue X, Smie\u0161ko M, van Son H, Wagner B, Berger N, Sfyroera G, Gros P, Lambris JD, Ricklin D. Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors. Nat Commun. 2022;13(1):5519.","journal-title":"Nat Commun"},{"issue":"3","key":"3924_CR164","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s15010-022-01904-w","volume":"51","author":"I Madurka","year":"2023","unstructured":"Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, Ulrik CS, Bhatnagar S, Krishnamurthy S, Mc Harry K, et al. DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function. Infection. 2023;51(3):641\u201354.","journal-title":"Infection"},{"key":"3924_CR165","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, Remi\u00e3o F, Silva R. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther. 2023;244:108373.","journal-title":"Pharmacol Ther"},{"issue":"11","key":"3924_CR166","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1021\/acsmedchemlett.0c00293","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu J, Bandyopadhyay I, Zheng L, Khdour OM, Hecht SM. Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease. ACS Med Chem Lett. 2020;11(11):2165\u201373.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"3924_CR167","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-022-00990-0","volume":"14","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette A, Palmqvist S, Bali D, Farrar G, Buckley CJ, Wolk DA, Zetterberg H, Blennow K, Janelidze S, Hansson O. Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer\u2019s dementia in mild cognitive impairment patients. Alzheimers Res Ther. 2022;14(1):46.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3924_CR168","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13195-024-01620-7","volume":"16","author":"B Kovacech","year":"2024","unstructured":"Kovacech B, Cullen NC, Novak P, Hanes J, Kontsekova E, Katina S, Parrak V, Fresser M, Vanbrabant J, Feldman HH, et al. Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer\u2019s disease, positive for plasma p-tau217. Alzheimers Res Ther. 2024;16(1):254.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"3924_CR169","doi-asserted-by":"publisher","first-page":"802","DOI":"10.14283\/jpad.2024.122","volume":"11","author":"RA Sperling","year":"2024","unstructured":"Sperling RA, Donohue MC, Rissman RA, Johnson KA, Rentz DM, Grill JD, Heidebrink JL, Jenkins C, Jimenez-Maggiora G, Langford O, et al. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimers Dis. 2024;11(4):802\u201313.","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"3924_CR170","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/alz.70038","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang J, Huang S, Lan G, Lai YJ, Wang QH, Chen Y, Xiao ZS, Chen X, Bu XL, Liu YH, et al. Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts. Alzheimers Dement. 2025;21(3):e70038.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"3924_CR171","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","volume":"112","author":"D Zhang","year":"2024","unstructured":"Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, et al. P-tau217 correlates with neurodegeneration in Alzheimer\u2019s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron. 2024;112(10):1676\u2013e16931612.","journal-title":"Neuron"},{"issue":"8","key":"3924_CR172","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","volume":"15","author":"BS Franklin","year":"2014","unstructured":"Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, Engels G, Brenker C, Nordhoff M, Mirandola SR, Al-Amoudi A, et al. The adaptor ASC has extracellular and \u2018prionoid\u2019 activities that propagate inflammation. Nat Immunol. 2014;15(8):727\u201337.","journal-title":"Nat Immunol"},{"issue":"1","key":"3924_CR173","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1038\/s41467-024-53547-0","volume":"15","author":"E Lobanova","year":"2024","unstructured":"Lobanova E, Zhang YP, Emin D, Brelstaff J, Kahanawita L, Malpetti M, Quaegebeur A, Triantafilou K, Triantafilou M, Zetterberg H, et al. ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases. Nat Commun. 2024;15(1):9690.","journal-title":"Nat Commun"},{"issue":"8","key":"3924_CR174","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ni.2919","volume":"15","author":"A Baroja-Mazo","year":"2014","unstructured":"Baroja-Mazo A, Mart\u00edn-S\u00e1nchez F, Gomez AI, Mart\u00ednez CM, Amores-Iniesta J, Compan V, Barber\u00e0-Cremades M, Yag\u00fce J, Ruiz-Ortiz E, Ant\u00f3n J, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014;15(8):738\u201348.","journal-title":"Nat Immunol"},{"issue":"16","key":"3924_CR175","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.7150\/thno.97149","volume":"14","author":"M Shojaei","year":"2024","unstructured":"Shojaei M, Schaefer R, Schlepckow K, Kunze LH, Struebing FL, Brunner B, Willem M, Bartos LM, Feiten A, Palumbo G, et al. PET imaging of microglia in Alzheimer\u2019s disease using copper-64 labeled TREM2 antibodies. Theranostics. 2024;14(16):6319\u201336.","journal-title":"Theranostics"},{"key":"3924_CR176","doi-asserted-by":"crossref","unstructured":"Gagnon M, Savard M, Tran TMH, Vincent L, Moquin A, Tremblay P, Roucou X, Dory Y, Gobeil F. Evaluation of Novel B1R\/B2R Agonists Containing TRIOZAN\u2122 Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease. Molecules. 2023;28(13):5206.","DOI":"10.3390\/molecules28135206"},{"issue":"4","key":"3924_CR177","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR Jr., Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367\u201385.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3924_CR178","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","volume":"17","author":"R Ismail","year":"2020","unstructured":"Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, Kjeldsen PL, Stokholm MG, Gottrup H, Eskildsen SF, et al. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study. J Neuroinflammation. 2020;17(1):151.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3924_CR179","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11307-025-01991-9","volume":"27","author":"M Salarian","year":"2025","unstructured":"Salarian M, Liu S, Tsai HM, Leslie SN, Hayes T, Lo ST, Szardenings AK, Zhang W, Chen G, Sandiego C, et al. Evaluation of [(18)F]JNJ-CSF1R-1 as a Positron Emission Tomography Ligand Targeting Colony-Stimulating Factor 1 Receptor. Mol Imaging Biol. 2025;27(2):163\u201372.","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"3924_CR180","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Xiang X, Li Y, Bu G, Chen XF. TREM2 and sTREM2 in Alzheimer\u2019s disease: from mechanisms to therapies. Mol Neurodegener. 2025;20(1):43.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"3924_CR181","doi-asserted-by":"publisher","first-page":"823","DOI":"10.14283\/jpad.2024.134","volume":"11","author":"RA Rissman","year":"2024","unstructured":"Rissman RA, Donohue MC, Langford O, Raman R, Abdel-Latif S, Yaari R, Holdridge KC, Sims JR, Molina-Henry D, Jimenez-Maggiora G, et al. Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer\u2019s Disease. J Prev Alzheimers Dis. 2024;11(4):823\u201330.","journal-title":"J Prev Alzheimers Dis"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03924-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:26Z","timestamp":1790078606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03924-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":181,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3924"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03924-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"317"}}